These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1566481)

  • 1. Inhibition of natural antibody production by a combination of 15-deoxyspergualin, mizoribine, cyclophosphamide, and splenectomy.
    Leventhal JR; Flores HC; Gruber SA; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):687. PubMed ID: 1566481
    [No Abstract]   [Full Text] [Related]  

  • 2. Down-regulation of xenophile antibodies by 15-deoxyspergualin in an experimental animal model.
    Ulrichs K; Wang H; Müller-Ruchholtz W
    Transplant Proc; 1994 Apr; 26(2):994-6. PubMed ID: 8171724
    [No Abstract]   [Full Text] [Related]  

  • 3. Mizoribine inhibits natural antibody production in a discordant xenograft model.
    Flores HC; Leventhal JR; Gruber SA; Schaffer MM; Bolman RM; Matas AJ
    Transplant Proc; 1992 Apr; 24(2):717. PubMed ID: 1566497
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of natural antibody synthesis by cyclophosphamide or 15-deoxyspergualin fails to prevent xenograft rejection in the guinea pig-to-rat model.
    Leventhal JR; Platt JL; Flores HC; Gruber SA; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):551. PubMed ID: 1566426
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
    Blakely ML; Van der Werf WJ; Dalmasso AP; Bach FH
    Transplant Proc; 1994 Jun; 26(3):1374-5. PubMed ID: 8029946
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model.
    Flores HC; Leventhal JR; Gruber SA; Figueroa J; Platt JL; Manivel C; Bach FH; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):714. PubMed ID: 1566495
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide.
    Ulrichs K; Kaitschick J; Bartlett R; Müller-Ruchholtz W
    Transplant Proc; 1992 Apr; 24(2):718-9. PubMed ID: 1566498
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model.
    Leventhal JR; Flores HC; Gruber SA; Figueroa J; Platt JL; Manivel JC; Bach FH; Matas AJ; Bolman RM
    Transplantation; 1992 Jul; 54(1):26-31. PubMed ID: 1631940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive mode of action of deoxyspergualin in mice, as compared with cyclosporine A and mizoribine.
    Okubo M; Masaki Y; Kamata K; Sato N; Inoue K; Umetani N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1085-7. PubMed ID: 2784882
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
    Murase N; Demetris AJ; Tanabe M; Miyazawa H; Valdivia LA; Nakamura K; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):425-6. PubMed ID: 7679817
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of plasmapheresis and deoxyspergualin or cyclophosphamide treatment on anti-porcine Gal-alpha (1,3)-Gal antibody titres in humans.
    Gannedahl G; Tufveson G; Sundberg B; Groth CG
    Transplant Proc; 1996 Apr; 28(2):551. PubMed ID: 8623262
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful down-regulation of natural and xenoreactive antibodies in pig-to-baboon xenotransplantation by high-dose cyclophosphamide.
    Morschheuser T; Steinhoff G; Indzhiia L; Heiser A; Hein M; Lapin BA; Haverich A
    Transplant Proc; 1997; 29(1-2):970-2. PubMed ID: 9123612
    [No Abstract]   [Full Text] [Related]  

  • 13. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates.
    Leventhal JR; Sakiyalak P; Witson J; Simone P; Matas AJ; Bolman RM; Dalmasso AP
    Transplantation; 1994 Mar; 57(6):974-8. PubMed ID: 8154049
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term suppression of natural and graft-induced xenophile antibodies by short-term antigen-cyclophosphamide treatment.
    Breitkreuz A; Ulrichs K; Eckstein V; Müller-Ruchholtz W
    Transplant Proc; 1993 Feb; 25(1 Pt 1):416-8. PubMed ID: 8438359
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of antibody production by the immunosuppressive agent, 15-deoxyspergualin.
    Tepper MA; Petty B; Bursuker I; Pasternak RD; Cleaveland J; Spitalny GL; Schacter B
    Transplant Proc; 1991 Feb; 23(1 Pt 1):328-31. PubMed ID: 1990547
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained suppression of xenoreactive natural antibodies: anti-IgM monoclonal antibody and anti-B cell immunosuppressants.
    Van der Werf WJ; Blakely ML; Hancock W; Soares M; Latinne D; Bazin H; Bach FH
    Transplant Proc; 1994 Jun; 26(3):1372-3. PubMed ID: 8029945
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of rat xenoantibodies with guinea pig liver antigen and pulse cyclophosphamide.
    Goldberg LC; Buckland EJ; Taube D
    Transplant Proc; 1994 Jun; 26(3):1276-8. PubMed ID: 8029907
    [No Abstract]   [Full Text] [Related]  

  • 18. 15-Deoxyspergualin and mouse to rat heart retransplantation.
    Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
    Transplant Proc; 1992 Apr; 24(2):710-1. PubMed ID: 1566493
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunosuppressive effect and mode of action of cyclosporin A (Cy A) and mizoribine (MZR) on humoral immune response in mice].
    Okubo M; Chen XM; Kamata K; Masaki Y; Uchiyama T
    Nihon Jinzo Gakkai Shi; 1986 Jan; 28(1):51-9. PubMed ID: 3486988
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide inhibition of anamnestic humoral immunity.
    Schulak JA; McBride JL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1147-9. PubMed ID: 2650082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.